Sarah Duncan Insider Profile
4 Followers
Sarah Duncan, Chief Financial Officer at Circassia Pharmaceuticals, holds 137.01K shares in Circassia Pharmaceuticals (Ticker: GB:NIOX).
Sarah Duncan Circassia Pharmaceuticals (NIOX)Chief Financial Officer
Circassia Pharmaceuticals (NIOX)
Chief Financial Officer
Ranked #66,425 out of 107,360 Corporate Insiders
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-13.20%
Average return per transaction
Time Frame
Compare to
Insider Roles
Chief Financial Officer
Roles that Sarah Duncan holds in companies
Most Profitable Insider Trade
The most profitable trade made by Sarah Duncan
Sarah Duncan's Trading History
List of latest transactions for each holding click on a transaction to see Sarah Duncan's performance on stock
You May Also Like
Sarah Duncan insider profile FAQ
What is the percentage of profitable transactions made by Sarah Duncan?
The percentage of profitable transactions made by Sarah Duncan is 0%.
What is the average return per transaction made by Sarah Duncan?
The average return per transaction made by Sarah Duncan is -13.20%.
What stocks does Sarah Duncan hold?
Sarah Duncan holds: GB:NIOX stocks.
What was Sarah Duncan’s latest transaction?
Sarah Duncan latest transaction was an Uninformative Sell of 236.88 p.
What was Sarah Duncan's most profitable transaction?
Sarah Duncan’s most profitable transaction was an Informative Sell of GB:NIOX stock on April 17, 2026. The return on the trade was -6.90%.
What is Sarah Duncan's role in Circassia Pharmaceuticals?
Sarah Duncan's role in Circassia Pharmaceuticals is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.